NO996291D0 - Anvendelse av intravenoese kontrastmidler og anordninger for projeksjonsmammografi - Google Patents

Anvendelse av intravenoese kontrastmidler og anordninger for projeksjonsmammografi

Info

Publication number
NO996291D0
NO996291D0 NO996291A NO996291A NO996291D0 NO 996291 D0 NO996291 D0 NO 996291D0 NO 996291 A NO996291 A NO 996291A NO 996291 A NO996291 A NO 996291A NO 996291 D0 NO996291 D0 NO 996291D0
Authority
NO
Norway
Prior art keywords
projection mammography
contrast agents
intravenous
mammography
devices
Prior art date
Application number
NO996291A
Other languages
English (en)
Other versions
NO996291L (no
NO315638B1 (no
Inventor
Ulrich Speck
Irtel Von Brenndorff
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO996291D0 publication Critical patent/NO996291D0/no
Publication of NO996291L publication Critical patent/NO996291L/no
Publication of NO315638B1 publication Critical patent/NO315638B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0457—Semi-solid forms, ointments, gels, hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
NO19996291A 1997-06-20 1999-12-17 Anvendelse av intravenöse kontrastmidler for projeksjonsmammografi NO315638B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97250190A EP0885616A1 (de) 1997-06-20 1997-06-20 Verwendung von intravenösen Kontrastmitteln sowie Vorrichtungen für die Projektionsmammographie
PCT/EP1998/003658 WO1998058679A1 (de) 1997-06-20 1998-06-19 Verwendung von intravenösen kontrastmitteln für die projektionsmammographie

Publications (3)

Publication Number Publication Date
NO996291D0 true NO996291D0 (no) 1999-12-17
NO996291L NO996291L (no) 1999-12-17
NO315638B1 NO315638B1 (no) 2003-10-06

Family

ID=8229158

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19996291A NO315638B1 (no) 1997-06-20 1999-12-17 Anvendelse av intravenöse kontrastmidler for projeksjonsmammografi
NO996292A NO996292L (no) 1997-06-20 1999-12-17 Anordning for projeksjonsmammografi

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO996292A NO996292L (no) 1997-06-20 1999-12-17 Anordning for projeksjonsmammografi

Country Status (28)

Country Link
US (2) US20020031475A1 (no)
EP (3) EP0885616A1 (no)
JP (3) JP4664449B2 (no)
KR (2) KR20010013980A (no)
CN (2) CN1263449A (no)
AT (1) ATE229820T1 (no)
AU (2) AU747033B2 (no)
BG (2) BG64895B1 (no)
BR (2) BR9810205A (no)
CA (2) CA2294187A1 (no)
CZ (1) CZ298462B6 (no)
DE (1) DE59806743D1 (no)
DK (1) DK0994729T3 (no)
HK (1) HK1029759A1 (no)
HU (2) HU225522B1 (no)
IL (2) IL133574A (no)
NO (2) NO315638B1 (no)
NZ (2) NZ501603A (no)
PL (2) PL337286A1 (no)
RS (1) RS49734B (no)
RU (1) RU2194533C2 (no)
SI (2) SI20152A (no)
SK (2) SK181199A3 (no)
TR (2) TR199903144T2 (no)
UA (1) UA71895C2 (no)
WO (2) WO1998058679A1 (no)
YU (1) YU66299A (no)
ZA (1) ZA985395B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10118792B4 (de) * 2001-04-05 2005-12-22 Schering Ag Anordnung zur Aufnahme von Projektionsmammogrammen und Verwendung der Anordnung für die Projektionsmammographie
FR2823969B1 (fr) * 2001-04-30 2003-12-26 Ge Med Sys Global Tech Co Llc Procede de prelevement d'un tissu au cours d'un examen par rayons x et dispositif de mise en oeuvre
DE102005033235A1 (de) * 2005-07-15 2007-01-18 Siemens Ag Verfahren zur Visualisierung eines vaskulären Einsatzstücks
US20080167552A1 (en) * 2007-01-04 2008-07-10 General Electric Company System and method of generating an image of a contrast agent injected into an imaged subject
FR2927719B1 (fr) 2008-02-19 2010-03-26 Gen Electric Procede de traitement d'images obtenues par tomosynthese et dispositif associe
US8315449B2 (en) * 2008-06-24 2012-11-20 Medrad, Inc. Identification of regions of interest and extraction of time value curves in imaging procedures
JP2012055549A (ja) * 2010-09-10 2012-03-22 Fujifilm Corp バイオプシ用ファントム
FR2967888B1 (fr) * 2010-11-26 2012-12-21 Gen Electric Procede de galactographie et mammographe pour l'execution dudit procede
US9651138B2 (en) 2011-09-30 2017-05-16 Mtd Products Inc. Speed control assembly for a self-propelled walk-behind lawn mower
DE102012217301B4 (de) 2012-09-25 2021-10-14 Bayer Pharma Aktiengesellschaft Kombination aus Kontrastmittel und Mammographie-CT-System mit vorgegebenem Energiebereich und Verfahren zur Erzeugung tomographischer Mammographie-CT-Aufnahmen durch diese Kombination
EA036245B1 (ru) * 2017-10-26 2020-10-16 Казахский научно-исследовательский институт онкологии и радиологии Способ диагностики рака молочной железы
EP3498306A1 (de) * 2017-12-16 2019-06-19 Bionorica SE Extrakte aus vitex agnus castus zur behandlung und diagnose von brustkrebs

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
FR2541272A1 (fr) * 1983-02-23 1984-08-24 Guerbet Sa Composes bromes et produits opacifiants en contenant
WO1987002893A1 (en) * 1985-11-18 1987-05-21 Board Of Regents, The University Of Texas System Polychelating agents for image and spectral enhancement (and spectral shift)
US5260050A (en) * 1988-09-29 1993-11-09 Ranney David F Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
GB8906130D0 (en) * 1989-03-17 1989-05-04 Nycomed As Compositions
DE3938992A1 (de) * 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5844965A (en) * 1989-11-24 1998-12-01 Thomas Jefferson University Method and apparatus for using film density measurements of a radiograph to monitor the reproducibility of X-ray exposure parameters of a mammography unit
DE4232925A1 (de) * 1992-09-28 1994-03-31 Diagnostikforschung Inst 3-,8-substituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel und Verfahren zu ihrer Herstellung
US5411730A (en) * 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles
DE4417628C1 (de) * 1994-05-19 1995-09-28 Siemens Ag Verfahren zur adaptiven Rauschverminderung für digitale Bildsequenzen
AU4173896A (en) * 1994-11-30 1996-06-19 Schering Aktiengesellschaft Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts
US5756066A (en) * 1995-06-07 1998-05-26 Schering Aktiengesellschaft Iodine-containing peptides
US5804164A (en) * 1996-03-13 1998-09-08 Research Corporation Technologies, Inc. Water-soluble lipophilic contrast agents
US6009342A (en) * 1997-02-28 1999-12-28 The Regents Of The University Of California Imaging method for the grading of tumors

Also Published As

Publication number Publication date
JP2002505679A (ja) 2002-02-19
NZ501603A (en) 2002-02-01
KR100582980B1 (ko) 2006-05-24
CZ460999A3 (cs) 2000-04-12
NZ501602A (en) 2002-02-01
CN1212862C (zh) 2005-08-03
SK181199A3 (en) 2000-07-11
HUP0003097A1 (hu) 2001-01-29
EP0991356A1 (de) 2000-04-12
JP4664449B2 (ja) 2011-04-06
RU2194533C2 (ru) 2002-12-20
SI20148A (sl) 2000-08-31
CZ298462B6 (cs) 2007-10-10
JP2002504843A (ja) 2002-02-12
KR20010013980A (ko) 2001-02-26
IL133574A0 (en) 2001-04-30
CA2294502A1 (en) 1998-12-30
KR20010013979A (ko) 2001-02-26
SK282716B6 (sk) 2002-11-06
CA2294187A1 (en) 1998-12-30
DK0994729T3 (da) 2003-03-10
NO996292D0 (no) 1999-12-17
NO996291L (no) 1999-12-17
SI20152A (sl) 2000-08-31
YU66299A (sh) 2002-09-19
UA71895C2 (en) 2005-01-17
EP0885616A1 (de) 1998-12-23
CN1263474A (zh) 2000-08-16
RS49734B (sr) 2008-04-04
BR9810215A (pt) 2000-08-08
PL337286A1 (en) 2000-08-14
YU66199A (sh) 2002-10-18
US20020031475A1 (en) 2002-03-14
TR199903140T2 (xx) 2000-05-22
PL191807B1 (pl) 2006-07-31
PL337287A1 (en) 2000-08-14
HU225522B1 (en) 2007-01-29
SK171299A3 (en) 2000-05-16
WO1998058679A1 (de) 1998-12-30
DE59806743D1 (de) 2003-01-30
NO315638B1 (no) 2003-10-06
CN1263449A (zh) 2000-08-16
IL133573A0 (en) 2001-04-30
JP2011012074A (ja) 2011-01-20
IL133574A (en) 2004-03-28
AU747033B2 (en) 2002-05-09
EP0994729B1 (de) 2002-12-18
EP0994729A1 (de) 2000-04-26
AU8337998A (en) 1999-01-04
BG104017A (en) 2000-05-31
BG64895B1 (bg) 2006-08-31
BR9810205A (pt) 2000-08-08
ATE229820T1 (de) 2003-01-15
NO996292L (no) 1999-12-17
WO1998058585A1 (de) 1998-12-30
ZA985395B (en) 1999-04-07
AU8627198A (en) 1999-01-04
HUP0003097A3 (en) 2003-07-28
BG104018A (en) 2000-05-31
HUP0003096A1 (hu) 2001-01-29
TR199903144T2 (xx) 2000-08-21
HK1029759A1 (en) 2001-04-12
US20050008574A1 (en) 2005-01-13
CA2294502C (en) 2009-03-31

Similar Documents

Publication Publication Date Title
CA2427590A1 (en) Evaluating disease progression using magnetic resonance imaging
NO996291D0 (no) Anvendelse av intravenoese kontrastmidler og anordninger for projeksjonsmammografi
NO854765L (no) Anvendelse av ferromagnetiske partikler i kontrastmidler for nmr-avbildning og kontrastmidler.
NO984543L (no) Bioaktiverte diagnostiske imaging kontrastmidler
WO1992018165A3 (en) Improved fluorocarbon contrast media for use with MRI and radiographic imaging
NO923821L (no) Diagnostiske midler
CL2004001126A1 (es) Complejos de polimeros en cascada y sus composiciones farmaceuticas, utiles para la preparacion de agentes de diagnostico por nmr.
ES2138970T3 (es) Medios de contraste.
SE8701905L (sv) Foerfarande och kit foer diagnos av iga-nefropati
DK0568554T3 (da) Fremgangsmåde til påvisning af anti-RNA-antistoffer
SU959107A1 (ru) Устройство дл считывани информации с перфокарт
ATE411531T1 (de) Auslesereihenfolge beim sammeln radialer magnetresonanz-bilddaten
EP1640737A3 (en) Evaluating disease progression using magnetic resonance imaging
Ronal EDITOR'S NOTE: Pleaseusecautionwhenrepeatingthisstudy. Duetothemanufacturer'smodification
Watt Anaerobic Infections in Humans, Sydney M. Finegold, W. Lance George (Eds.), Academic Press, Oxford (1989), p. 851
FI881679A (fi) Anordning foer fastgoerande av en givare vid en patients vaevnad.
JPS52128212A (en) Reagents for detecting alpha-l-antigen and alpha-l-antibody

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees